Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Not stated	2026-06-05		NCT06240195

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Azienda Policlinico Umberto I	12
Campus Bio-Medico University	26
Catholic University of the Sacred Heart	38
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	491
Hospital San Pietro Fatebenefratelli	2
Ospedale "Gaetano Bernabeo" , Ortona	1
Ospedale "SS Annunziata", Chieti	1
Ospedale di Belcolle - Viterbo	1
Ospedale Sandro Pertini, Roma	1
presidio Ospedaliero santo spirito in Sassia, Roma	1
Regina Elena Cancer Institute	39
San Giovanni Addolorata Hospital	6

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
"Regina Elena" National Cancer Institute	Rome	Italy	8